Table 1.
Timepoints (months) | Age group | Type of diabetes | Number of trials | Change in HbA1c (%) | Lower CL | Upper CL | Q | I2 | P value | τ2 |
---|---|---|---|---|---|---|---|---|---|---|
3–4 | Adults | T1DM | 16 | − 0.53 | − 0.69 | − 0.38 | 181.1 | 91.7 | < 0.0001 | 0.06574 |
3–4 | Adults | T2DM | 5 | − 0.45 | − 0.57 | − 0.33 | 9.9 | 59.5 | 0.0427 | 0.00000 |
4.5–7.5 | Adults | T1DM | 23 | − 0.42 | − 0.58 | − 0.27 | 336.5 | 93.5 | < 0.0001 | 0.1030 |
4.5–7.5 | Adults | T2DM | 9 | − 0.59 | − 0.80 | − 0.39 | 71.9 | 88.9 | < 0.0001 | 0.06313 |
There was substantial heterogeneity between trials, with I2 above 75% in T1DM at each timepoint. For T2DM, I2 was also above 75% at 4.5–7.5 months, with other timepoints comprising 5 or fewer trials
T1DM, type 1 diabetes; T2DM, type 2 diabetes